Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

NCT00902824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NETWORK

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ADVAX
BIOLOGICAL: TBC-M4
OTHER: Placebo

Sponsor

International AIDS Vaccine Initiative